Creating, facilitating and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe
Creating, facilitating and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe
Deliverable D4.4 on Endpoints is now published.
EUnetHTA 21 is pleased to announce the publication of the deliverable D4.4 on Endpoints. The objective of this deliverable was to develop a practical guideline on how to
EUnetHTA 21 announces publication of five deliverables
EUnetHTA 21 is pleased to announce the publication of five deliverables: D4.3.1 Practical guideline for direct and indirect comparisons, D4.5 Practical guideline on applicability of
[New] Patient input and healthcare professional input requested for second medical device Joint Clinical Assessment.
EUnetHTA 21 is pleased to announce it has started a second Joint Clinical Assessment on a medical device. The technology under assessment is a device
Patient input and healthcare professional input requested for first medical device Joint Clinical Assessment
EUnetHTA 21 is pleased to announce it has started a Joint Clinical Assessment on a medical device for male patients with urinary symptoms associated with
EUnetHTA 21-EMA Bilateral Meeting Minutes available now.
We are pleased to announce the publication of the EUnetHTA 21 – EMA bilateral meeting minutes. The joint meeting was held in June 2022. It
Updated documents for Joint Scientific Consultations (JSCs) now available.
The Guidance on Parallel EMA/EUnetHTA 21 JSC and the Briefing Book Template have been updated and are now available on the EUnetHTA 21 JSC website:
COVID-19 Response
EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.
Services
EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Assessments, Early Dialogues, and Post Launch Evidence Generation (PLEG). Find out more here.
Assessments
Pharmaceutical Joint Assessments (PTJA) and Other Technologies Collaborative Assessments (OTCA) are key EUnetHTA outputs. Find current project status, EUnetHTA Prioritisation List (EPL) and Topic Identification, Selection, and Prioritisation (TISP), uptake data and archived content here.
Tools
EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.
Get Involved
EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.
COVID-19 Response
EUnetHTA has prioritised COVID-19-related initiatives above other work during the current
time. Here you will find updated information and publications relating to COVID-19 diagnostic
testing, therapeutic treatments, and useful links to further data from our network partners.
Services
EUnetHTA develops several services that help inform the decision-making process around the
introduction of pharmaceuticals and other technologies at the national, regional, and
European levels. These include Joint Assessments, Early Dialogues, and Post Launch Evidence
Generation (PLEG). Find out more here.
Assessments
Pharmaceutical Joint Assessments (PTJA) and Other Technologies Collaborative Assessments
(OTCA) are key EUnetHTA outputs. Find current project status, EUnetHTA Prioritisation List
(EPL) and Topic Identification, Selection, and Prioritisation (TISP), uptake data and archived
content here.
Tools
EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint
work process, helping partners to proceed with a defined methodology. Access all current and
archived tools here.
Get Involved
EUnetHTA functions as a collaboration between network members and exterior partners to
develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out
more about partner involvement, activities, and EUnetHTA events here.
